SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-012175
Filing Date
2019-08-13
Accepted
2019-08-13 14:31:17
Documents
73
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 955390
2 form10-q_001.jpg GRAPHIC 5132
3 ex31-1.htm EX-31.1 18348
4 ex32-1.htm EX-32.1 8544
  Complete submission text file 0001493152-19-012175.txt   4178269

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE owpc-20190630.xml EX-101.INS 740351
6 XBRL SCHEMA FILE owpc-20190630.xsd EX-101.SCH 41337
7 XBRL CALCULATION FILE owpc-20190630_cal.xml EX-101.CAL 64133
8 XBRL DEFINITION FILE owpc-20190630_def.xml EX-101.DEF 141764
9 XBRL LABEL FILE owpc-20190630_lab.xml EX-101.LAB 269644
10 XBRL PRESENTATION FILE owpc-20190630_pre.xml EX-101.PRE 242994
Mailing Address 3471 WEST OQUENDO ROAD, SUITE 301 LAS VEGAS NV 89118
Business Address 3471 WEST OQUENDO ROAD, SUITE 301 LAS VEGAS NV 89118 7026050605
One World Pharma, Inc. (Filer) CIK: 0001622244 (see all company filings)

IRS No.: 611744826 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-200529 | Film No.: 191019873
SIC: 2834 Pharmaceutical Preparations